Rajan Gosain, MD
Psychiatry · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Lgtc Group · Wk Medical Group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gosain’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A132233 · Current
Licensed to practise in California · since 2014 · expires 2027-12-31 · Saba University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$55,791
Medicare paid this office $55,791 for 20 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 19 | $18,495 | $104 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $8,244 | $58 |
| Psychotherapy with evaluation and management visit, 45 minutes | 11 | $2,680 | $74 |
Who their Medicare patients are
20 Original Medicare patients in 2024. Average age 73 · Health risk score 0.98. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 60%.
The office billed $235,800, Medicare allowed $71,004 and paid $55,791; for 614 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 20 | 614 | 73 | 0.98 | $235,800 | $55,791 |
| 2023 | 18 | 333 | 73 | 1.02 | $143,000 | $30,895 |
| 2022 | 14 | 390 | 72 | 1.52 | $155,300 | $35,359 |
| 2021 | 16 | 218 | 75 | 0.74 | $61,260 | $19,659 |
| 2017 | 31 | 70 | 51 | 2.01 | $12,290 | $4,288 |
| 2016 | 30 | 93 | 48 | 1.24 | $14,111 | $5,562 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 12 | $7,918 | $104 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $3,634 | $55 |
2022: 2 services
| Return visit (30+ min) | 13 | $9,713 | $102 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $4,747 | $57 |
2021: 4 services
| Return visit (30+ min) | 14 | $6,970 | $109 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $3,302 | $58 |
| New patient visit (45+ min) | 13 | $1,659 | $128 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $1,628 | $74 |
2017: 1 service
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $976 | $30 |
2016: 4 services
| Psychiatric diagnostic evaluation with medical services | 15 | $1,604 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,354 | $54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $1,033 | $30 |
| Hospital discharge day management, more than 30 minutes | 11 | $963 | $80 |
Drugs they prescribed that Part D paid
$11,216
Pharmacies billed $11,216 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 223) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
212 generic and 11 brand-name prescriptions · $11,216 in drug cost · 19 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 22 | $312 | $14 |
| Bupropion Xl | 13 | $180 | $14 |
| Escitalopram | 29 | $167 | $6 |
| Mirtazapine | 12 | $129 | $11 |
| Doxepin | 11 | $87 | $8 |
See all 7 drugs
| Gabapentin | 22 | $312 | $14 |
| Bupropion Xl | 13 | $180 | $14 |
| Escitalopram | 29 | $167 | $6 |
| Mirtazapine | 12 | $129 | $11 |
| Doxepin | 11 | $87 | $8 |
| Clonazepam | 14 | $73 | $5 |
| Lorazepam | 13 | $24 | $2 |
Year by year
| 2024 | 223 | 23 | 0% (0) | 5% | $11,216 |
| 2023 | 153 | 18 | 0% (0) | None | $10,560 |
| 2022 | 125 | 11 | 0% (0) | 14% | $7,472 |
| 2021 | 91 | 14 | 0% (0) | None | $3,901 |
| 2020 | 24 | None | 0% (0) | 0% | $462 |
| 2018 | 66 | None | 0% (0) | None | $2,833 |
| 2017 | 84 | None | None | None | $2,836 |
| 2016 | 33 | None | None | None | $1,543 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Gabapentin | 17 | $257 | $15 |
| Clonazepam | 13 | $70 | $5 |
2022: 4 drugs
| Lamictal | 11 | $4,665 | $424 |
| Clonazepam | 13 | $58 | $4 |
| Sertraline | 13 | $35 | $3 |
| Lorazepam | 14 | $24 | $2 |
2021: 1 drug
| Clonazepam | 19 | $63 | $3 |
2017: 2 drugs
| Quetiapine | 11 | $159 | $14 |
| Clonazepam | 14 | $40 | $3 |
Money from drug and device companies
$77 in 2025
| 2025 | 2 | 3 | None | $77 |
| 2023 | 1 | 1 | None | $24 |
| 2022 | 3 | 6 | None | $125 |
| 2021 | 2 | 5 | None | $80 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $56 | 2 payments
|
| Bausch Health US | Wellbutrin | $22 | 1 payment
|
See all 3 published payments
| Otsuka America Pharmaceutical | Meals · 2025-06-17 | Rexulti | $26 |
| Bausch Health US | Meals · 2025-03-04 | Wellbutrin | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-01-22 | Rexulti | $29 |
See earlier years (2023, 2022, 2021)
2023: $24
| Bausch Health US | Aplenzin | $24 | 1 payment
|
2022: $125
| Janssen Pharmaceuticals | Spravato | $88 | 4 payments
|
| Bausch Health US | Aplenzin | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $16 | 1 payment
|
2021: $80
| AbbVie | Vraylar | $61 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $19 | 1 payment
|
Professional record
- NPI
- 1013271600
- Licence
- CA A132233, MA 252478California A132233: Current · expires 2027-12-31
- Group
- Lgtc Group · Wk Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 4140 De Mille Dr, San Jose, CA, 95117
- NPI first listed
- 2012-06-27
- NPI last updated
- 2022-07-21
- NPI record certified
- 2021-11-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2542 S Bascom Ave Ste 110, Campbell, CA, 95008